Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Leiden University Medical Center, Leiden, The Netherlands.
Pediatr Blood Cancer. 2010 Feb;54(2):216-21. doi: 10.1002/pbc.22293.
Resection of pulmonary metastases has previously been reported to improve outcome in high-grade osteosarcoma (OS) patients. Factors influencing survival in OS patients with pulmonary metastases are important for clinical decision making.
All 88 OS patients with pulmonary metastases either at diagnosis or during follow-up treated at the Leiden University Medical Center between January 1, 1990 and January 1, 2008 under the age of 40 were included in this study, including 79 cases of conventional, 8 cases of telangiectatic and 1 case of small cell OS.
In total, 56 of 88 patients with pulmonary metastases were treated by metastasectomy. Resectability of pulmonary metastases was the main prognostic factor. In patients with primary non-metastatic OS, a longer relapse free interval to pulmonary metastases was significantly associated with better survival (P = 0.02). Independent risk factors determining worse survival after metastasectomy in multivariate analysis were male sex (P = 0.05), higher number of pulmonary nodules (P = 0.03), and non-necrotic metastases (P = 0.04). Whether surgery for recurrent pulmonary metastases was performed did not influence survival. Histological subtype of the primary tumor, histological response in the primary tumor after neo-adjuvant chemotherapy, occurrence of local relapse, local resection or amputation of the primary tumor and age at diagnosis did not influence outcome.
This cohort of patients with detailed follow-up data enabled us to identify important risk factors determining survival in OS patients with pulmonary metastases. We demonstrate that after repeated metastasectomies, a subset of patients can be cured.
先前有研究报道,肺转移灶切除术可改善高级别骨肉瘤(OS)患者的预后。影响 OS 患者肺转移生存的因素对于临床决策至关重要。
本研究纳入了莱顿大学医学中心 1990 年 1 月 1 日至 2008 年 1 月 1 日期间年龄小于 40 岁、诊断或随访时发生肺转移的 88 例 OS 患者,包括 79 例经典型 OS、8 例毛细血管扩张型 OS 和 1 例小细胞 OS。
总共 88 例肺转移患者中有 56 例行转移灶切除术。肺转移灶的可切除性是主要的预后因素。在原发性非转移性 OS 患者中,肺转移前无病间期越长与生存时间延长显著相关(P = 0.02)。多变量分析显示,可切除性以外的影响转移灶切除术预后的独立危险因素为男性(P = 0.05)、肺转移灶数量较多(P = 0.03)和非坏死性转移灶(P = 0.04)。是否对复发性肺转移灶行手术治疗并不影响生存。肿瘤的组织学亚型、新辅助化疗后原发肿瘤的组织学反应、局部复发、局部切除或原发病灶截肢以及诊断时的年龄均不影响预后。
本研究队列患者具有详细的随访数据,使我们能够确定影响 OS 患者肺转移生存的重要危险因素。我们证明,经过多次转移灶切除术,部分患者可被治愈。